Rare diseases
Investigational molecules
Locations
Back to France785 clinical trials in Chambery, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)A study testing GSK3862995B compared to placebo for safety and effectiveness in adults aged 18 to 85 years with bronchiectasis
FranceA study comparing prasinezumab with placebo for people with early-stage Parkinson's disease
FranceStudy of oral cladribine compared to placebo for patients with generalized myasthenia gravis
FranceA study comparing odronextamab combined with chemotherapy versus rituximab combined with chemotherapy in adults with previously untreated follicular lymphoma
FranceLong-term Safety Study of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease and History of Exacerbations
FranceA Study of Telisotuzumab Adizutecan Compared to Standard Treatment in Adults with Advanced Non-Small Cell Lung Cancer After Previous Treatment
FranceStudy of chemotherapy with blinatumomab and tyrosine kinase inhibitors in newly diagnosed children and young adults with Philadelphia chromosome positive B-cell acute lymphoblastic leukemia
FranceA study testing visugromab, nivolumab, and lenvatinib for patients with advanced liver cancer that cannot be removed by surgery after previous treatment failed
FranceStudy of ivonescimab alone or with ligufalimab versus pembrolizumab for patients with recurrent or metastatic head and neck squamous cell cancer
FranceA Study of Felzartamab for Kidney Transplant Patients with Late Isolated Microvascular Inflammation
FranceStudy of Trastuzumab Deruxtecan and Pertuzumab for Patients with HER2-Positive Metastatic Breast Cancer Who Have Not Received Prior Treatment
FranceA Study of BMS-986504 Combined with Nab-Paclitaxel and Gemcitabine for Patients with Untreated Metastatic Pancreatic Cancer with MTAP Gene Deletion
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple myeloma and various lymphomas, evaluating novel therapeutic combinations and treatment strategies.
Advanced trials exploring combinations of immunotherapy and targeted treatments for blood cancers.
Studies examining innovative treatments for non-small cell lung cancer, particularly focusing on immunotherapy approaches.
Emphasis on improving treatment outcomes through targeted and combination therapies.
Research on pneumococcal vaccines and preventive treatments, including studies in specialized patient populations.
Focus on vaccine effectiveness during acute illness conditions.
Clinical trials examining treatments for hormone-sensitive breast cancer, including targeted therapies and hormone treatment optimization.
Investigation of personalized treatment approaches based on molecular markers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
